Ceragenins: A Synthesis of Nature and Innovation

Ceragenins are synthetic molecules modeled after host defense peptides, vital components of our innate immune system. Ceragenins mimic and enhances LL-37, reduce and inhibit IL-6, without creating antimicrobial resistance.

They exhibit an array of pharmacological activities, including antimicrobial and anti-inflammatory effects, similar to their natural counterparts.

Backed by extensive research (Since 2019 there have been 350 peer-reviewed journal articles about the Ceragenins technology), patents, and significant investments, Ceragenins are a breakthrough in medical science.
Featuring a sterol backbone adorned with amino acids and other groups, they have a positive charge that targets the negatively charged cell membranes of many pathogens.

LL37- Little peptide, big effects

Potent Antimicrobials: Beyond Conventional Approaches

Strong Anti-Inflammatory and Immunomodulatory Activities

Contact us

Lets Get in Touch!

Follow now


Basic contact form

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.